Endovascular treatment of renal artery stenosis in Germany: a retrospective analysis of the DEGIR registry 2018–2021

Abstract

Purpose To provide an overview of endovascular treatment of renal artery stenosis (RAS) using the data of the Deutsche Gesellschaft für interventionelle Radiologie (DeGIR) quality management system.

Materials and Methods A retrospective analysis was performed. Pre-, peri- and postprocedural data, technical success rates, complication rates, and clinical success rates at dismissal were examined.

Results Between 2018 and 2021, 2134 angiography examinations of the renal arteries were performed: diagnostic angiography in 70 patients (3 %), balloon angioplasty in 795 (37 %), stent implantation in 1166 (55 %) and miscellaneous procedures in 103 (5 %). The lesion length was less than or equal to 5 mm in 1837 patients (87 %), between 5 and 10 mm in 197 (9 %), and between 10 and 20 mm in 62 (3 %). The degree of stenosis was less than 50 % in 156 patients (7 %), greater than 50 % in 239 (11 %), and greater than 70 % in 1472 (70 %). Occlusion was treated in 235 patients (11 %). Symptoms at discharge resolved in 600 patients (29 %), improved in 1012 (49 %), were unchanged in 77 (4 %), and worsened in 5 (0.2 %). Complications were reported in 51 patients (2.5 %) and the mortality rate was 0.15 %.

Conclusion A substantial number of patients with RAS and occlusions were treated by radiologists in Germany, with high technical success rates and low complication rates. The indication should be determined carefully as the current European guidelines for the treatment of RAS suggest that only carefully selected groups of patients will benefit from recanalizing treatment.

Key Points: 

• Carefully selected patient groups may benefit from endovascular treatment of renal artery stenosis.

• Analysis of the DEGIR quality management database shows that treatment of renal artery stenosis was performed by radiologists in Germany with high technical success rates and low complication rates.

• Recanalization even led to symptom improvement in a large proportion of patients with occlusions.

Zusammenfassung

Hintergrund Es soll ein Überblick über die endovaskuläre Behandlung von Nierenarterienstenosen (RAS) anhand der Daten des Qualitätsmanagementsystems der Deutschen Gesellschaft für interventionelle Radiologie (DeGIR) gegeben werden.

Material und Methoden Es wurde eine retrospektive Analyse durchgeführt. Untersucht wurden prä-, peri- und postprozedurale Daten, technische Erfolgsraten, Komplikationsraten und klinische Erfolgsraten bei Entlassung.

Ergebnisse Zwischen 2018 und 2021 wurden 2134 Angiografien der Nierenarterien durchgeführt: diagnostische Angiografie in 70 (3 %), Ballonangioplastie in 795 (37 %), Stentimplantation in 1166 (55 %) und sonstige Verfahren in 103 (5 %). Die Länge der Läsion betrug bei 1837 (87 %) weniger als oder gleich 5 mm, bei 197 (9 %) zwischen 5 und 10 mm und bei 62 (3 %) der Patienten zwischen 10 und 20 mm. Der Grad der Stenose lag bei 156 (7 %) unter 50 %, bei 239 (11 %) über 50 % und bei 1472 (70 %) Patienten über 70 %. Ein Verschluss wurde bei 235 (11 %) der Patienten behandelt. Bei der Entlassung waren die Symptome bei 600 (29 %) behoben, bei 1012 (49 %) verbessert, bei 77 (4 %) unverändert und bei 5 (0,2 %) der Patienten verschlechtert. Komplikationen traten bei 51 (2,5 %) Patienten auf, und die Sterblichkeit lag bei 0,15 %.

Schlussfolgerung Eine beträchtliche Anzahl von Patienten mit RAS und Verschlüssen wurde in Deutschland von Radiologen behandelt, mit hohen technischen Erfolgsraten und niedrigen Komplikationsraten. Die Indikation sollte sorgfältig gestellt werden, da die aktuellen europäischen Leitlinien für die Behandlung von RAS nahelegen, dass nur sorgfältig ausgewählte Patientengruppen von einer rekanalisierenden Behandlung profitieren werden.

Kernaussagen: 

• Sorgfältig ausgewählte Patientengruppen können von einer endovaskulären Behandlung einer Nierenarterienstenose profitieren.

• Die Behandlung von Nierenarterienstenosen in Deutschland wurde von Radiologen mit hohen technischen Erfolgsraten und niedrigen Komplikationsraten durchgeführt.

• Die Rekanalisation führte sogar bei einem großen Teil der Patienten mit Verschlüssen zu Symptombesserungen.

Zitierweise

• Feyen L, Artzner C, Paprottka P et al. Endovascular treatment of renal artery stenosis in Germany: a retrospective analysis of the DEGIR registry 2018–2021. Fortschr Röntgenstr 2024; 196: 283 – 291

Key words

renal arteries - quality management - renal angiography - stents - renal artery occlusion - interventional procedures

Publication History

Received: 07 May 2023

Accepted: 18 September 2023

Article published online:
23 November 2023

• References

• 1 Investigators A, Wheatley K, Ives N. et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361: 1953-1962
• 2 Cooper CJ, Murphy TP, Cutlip DE. et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014; 370: 13-22
• 3 Jenks S, Yeoh SE, Conway BR. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis. Cochrane Database Syst Rev 2014; CD002944
• 4 Piaggio D, Bracale U, Pecchia L. et al. Endovascular Treatment versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review. Ann Vasc Surg 2019; 61: 445-454
• 5 Tian Y, Yuan B, Zhang N. et al. Outcomes Following the Endovascular Treatment of Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis. Ann Vasc Surg 2022; 78: 362-372
• 6 Aboyans V, Ricco JB, Bartelink MEL. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39: 763-816
• 7 Deutsche Gesellschaft für Gefäßchirurgie und Gefäßmedizin – Gesellschaft für operative eupGeVD. S2k-Leitlinie Erkrankungen der Nierenarterie. AWMF-Website; 2017.
• 8 Prince M, Tafur JD, White CJ. When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?. JACC Cardiovasc Interv 2019; 12: 505-517
• 9 Bohlke M, Barcellos FC. From the 1990s to CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial results and beyond: does stenting have a role in ischemic nephropathy?. Am J Kidney Dis 2015; 65: 611-622
• 10 Ritchie J, Green D, Chrysochou C. et al. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis 2014; 63: 186-197
• 11 Petrov I, Tasheva I, Garvanski I. et al. Recanalization and stenting of total occlusions of the renal arteries for blood pressure control in resistant to treatment hypertension. Cardiovasc Revasc Med 2018;
• 12 Navaravong L, Ali RG, Giugliano GR. Acute renal artery occlusion: making the case for renal artery revascularization. Cardiovasc Revasc Med 2011; 12: 399-402
• 13 Boyer L, Ravel A, De Fraissinette B. et al. [Percutaneous recanalization of occluded renal arteries]. J Mal Vasc 2000; 25: 377-381
• 14 Hinojosa-Gonzalez DE, Salgado-Garza G, Torres-Martinez M. et al. Endovascular Treatment of Transplant Renal Artery Stenosis: A Systematic Review and Meta-analysis. J Endovasc Ther 2022; 29: 294-306
• 15 Bucker A, Gross-Fengels W, Haage P. et al. [Qualification guideline of the German Roentgen Society and the German Society of Interventional Radiology and Minimal Invasive Therapy for performing interventional radiologic minimal invasive procedures on arteries and veins]. Fortschr Röntgenstr 2012; 184: 565-569
• 16 Team RC. R: A language and environment for statistical computing. In: Vienna, Austria: R Foundation for Statistical Computing;. 2019
• 17 Sacks D, McClenny TE, Cardella JF. et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14: S199-S202
• 18 Jiang X, Peng M, Li B. et al. The efficacy of renal artery stent combined with optimal medical therapy in patients with severe atherosclerotic renal artery stenosis. Curr Med Res Opin 2016; 32: 3-7
• 19 Sapoval M, Tamari I, Goffette P. et al. One year clinical outcomes of renal artery stenting: the results of ODORI Registry. Cardiovasc Intervent Radiol 2010; 33: 475-483
• 20 Watson PS, Hadjipetrou P, Cox SV. et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-1677
• 21 Rocha-Singh K, Jaff MR, Rosenfield K. et al. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 2005; 46: 776-783
• 22 Klein AJ, Jaff MR, Gray BH. et al. SCAI appropriate use criteria for peripheral arterial interventions: An update. Catheter Cardiovasc Interv 2017; 90: E90-E110
• 23 European StrokeO, Tendera M, Aboyans V. et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2851-2906
• 24 Olin JW, Gornik HL, Bacharach JM. et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014; 129: 1048-1078
• 25 Cragg AH, Smith TP, Thompson BH. et al. Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. Radiology 1989; 172: 145-147
• 26 Trinquart L, Mounier-Vehier C, Sapoval M. et al. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56: 525-532
• 27 Hansen KJ, Edwards MS, Craven TE. et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002; 36: 443-451
• 28 van de Ven PJ, Kaatee R, Beutler JJ. et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-286
• 29 Zeller T, Rastan A, Rothenpieler U. et al. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents?. Catheter Cardiovasc Interv 2006; 68: 125-130
• 30 Zahringer M, Pattynama PM, Talen A. et al. Drug-eluting stents in renal artery stenosis. Eur Radiol 2008; 18: 678-682
• 31 Grotti S, Liistro F, Angioli P. et al. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study. J Endovasc Ther 2016; 23: 52-57
• 32 Krankenberg H, Tubler T, Ingwersen M. et al. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial. Circulation 2015; 132: 2230-2236
• 33 Patel PM, Eisenberg J, Islam MA. et al. Percutaneous revascularization of persistent renal artery in-stent restenosis. Vasc Med 2009; 14: 259-264
• 34 Yang M, Lin L, Niu G. et al. Successful endovascular treatment of chronic renal artery occlusion: a preliminary retrospective case series including 15 patients. Int Urol Nephrol 2019; 51: 285-291
• 35 Sasaki Y, Mishima E, Kikuchi K. et al. Treatment of Refractory Hypertension with Timely Angioplasty in Total Renal Artery Occlusion with Atrophic Kidney. Intern Med 2021; 60: 287-292
• 36 Manohar S, Hamadah A, Herrmann SM. et al. Total Renal Artery Occlusion: Recovery of Function After Revascularization. Am J Kidney Dis 2018; 71: 748-753